Management of Treatment-Experienced HIV-Infected Patients

  • Author: Eric S. Daar, MD (More Info)
  • Section Editor: Eric S. Daar, MD
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 3/21/21 (What's New)

Summary

  • Few data are available on the optimal management of virologic failure with a first-line ritonavir-boosted PI regimen
  • A systematic review of multiple randomized, controlled trials of virologic failure with first-line ritonavir-boosted PI–based regimens showed that reinforced adherence and maintenance of the original regimen was as likely to result in virologic suppression as a modification in therapy[Zheng 2014]

Action required

Keywords: Management of Treatment-Experienced Patients, Resistance Testing

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.